Cargando…
The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
We investigate the mechanism associated with the severity of COVID-19 in men with TLR7 mutation. Men with loss-of-function (LOF) mutations in TLR7 had severe COVID-19. LOF mutations in TLR7 increased the risk of critical COVID by 16.00-fold (95% confidence interval 2.40–106.73). The deleterious muta...
Autores principales: | Naushad, Shaik Mohammad, Mandadapu, Gowtham, Ramaiah, Mekala Janaki, Almajhdi, Fahad N., Hussain, Tajamul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421879/ https://www.ncbi.nlm.nih.gov/pubmed/37567916 http://dx.doi.org/10.1038/s41598-023-40114-8 |
Ejemplares similares
-
Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019) -
Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008) -
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020) -
Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
por: Alharbi, Arwaf S, et al.
Publicado: (2020) -
Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8
por: Wang, Xiaoyu, et al.
Publicado: (2022)